CYP1A1, VEGFA and Adipokine Responses of Human Adipocytes Co-exposed to PCB126 and Hypoxia.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 07 2022
Historique:
received: 23 06 2022
revised: 19 07 2022
accepted: 20 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

It is increasingly recognized that hypoxia may develop in adipose tissue as its mass expands. Adipose tissue is also the main reservoir of lipophilic pollutants, including polychlorinated biphenyls (PCBs). Both hypoxia and PCBs have been shown to alter adipose tissue functions. The signaling pathways induced by hypoxia and pollutants may crosstalk, as they share a common transcription factor: aryl hydrocarbon receptor nuclear translocator (ARNT). Whether hypoxia and PCBs crosstalk and affect adipokine secretion in human adipocytes remains to be explored. Using primary human adipocytes acutely co-exposed to different levels of hypoxia (24 h) and PCB126 (48 h), we observed that hypoxia significantly inhibits the PCB126 induction of cytochrome P450 (CYP1A1) transcription in a dose-response manner, and that Acriflavine (ACF)-an HIF1α inhibitor-partially restores the PCB126 induction of CYP1A1 under hypoxia. On the other hand, exposure to PCB126 did not affect the transcription of the vascular endothelial growth factor-A (VEGFA) under hypoxia. Exposure to hypoxia increased leptin and interleukin-6 (IL-6), and decreased adiponectin levels dose-dependently, while PCB126 increased IL-6 and IL-8 secretion in a dose-dependent manner. Co-exposure to PCB126 and hypoxia did not alter the adipokine secretion pattern observed under hypoxia and PCB126 exposure alone. In conclusion, our results indicate that (1) hypoxia inhibits PCB126-induced CYP1A1 expression at least partly through ARNT-dependent means, suggesting that hypoxia could affect PCB metabolism and toxicity in adipose tissue, and (2) hypoxia and PCB126 affect leptin, adiponectin, IL-6 and IL-8 secretion differently, with no apparent crosstalk between the two factors.

Identifiants

pubmed: 35892579
pii: cells11152282
doi: 10.3390/cells11152282
pmc: PMC9331964
pii:
doi:

Substances chimiques

Adipokines 0
Adiponectin 0
Environmental Pollutants 0
Interleukin-6 0
Interleukin-8 0
Leptin 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
Aryl Hydrocarbon Receptor Nuclear Translocator 138391-32-9
Polychlorinated Biphenyls DFC2HB4I0K
CYP1A1 protein, human EC 1.14.14.1
Cytochrome P-450 CYP1A1 EC 1.14.14.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Annu Rev Pharmacol Toxicol. 1995;35:307-40
pubmed: 7598497
J Clin Invest. 2011 Jun;121(6):2094-101
pubmed: 21633177
Environ Int. 2014 Sep;70:15-24
pubmed: 24879368
Front Endocrinol (Lausanne). 2015 Feb 19;6:19
pubmed: 25745415
Toxicol Sci. 2011 Nov;124(1):1-22
pubmed: 21908767
Br J Nutr. 2008 Aug;100(2):227-35
pubmed: 18397542
Anesthesiology. 2004 Feb;100(2):274-80
pubmed: 14739800
Oxid Med Cell Longev. 2013;2013:640673
pubmed: 23577225
Biomolecules. 2015 Jun 08;5(2):1143-50
pubmed: 26061760
Compr Physiol. 2017 Sep 12;7(4):1085-1135
pubmed: 28915320
Toxicol Sci. 2018 Jun 1;163(2):440-453
pubmed: 29474705
Toxicol In Vitro. 2015 Feb;29(1):132-41
pubmed: 25304490
J Clin Endocrinol Metab. 2016 Apr;101(4):1422-8
pubmed: 26871994
Int J Obes (Lond). 2012 Jul;36(7):986-92
pubmed: 22005720
Exp Toxicol Pathol. 2014 Oct;66(8):377-82
pubmed: 24916446
Pflugers Arch. 2007 Dec;455(3):479-92
pubmed: 17609976
Biol Chem. 2004 Mar-Apr;385(3-4):291-4
pubmed: 15134343
Nucleic Acids Res. 2017 Jan 9;45(1):198-205
pubmed: 27694309
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17910-5
pubmed: 19805192
Toxicol Lett. 2005 Jan 15;155(1):151-9
pubmed: 15585370
Biochim Open. 2018 Jun 11;7:1-9
pubmed: 30003042
Mol Cell Biol. 1996 Oct;16(10):5221-31
pubmed: 8816435
Environ Health Perspect. 2020 Oct;128(10):107002
pubmed: 33026256
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1118-28
pubmed: 17666485
Biol Chem. 2006 Sep;387(9):1189-94
pubmed: 16972785
Acta Physiol (Oxf). 2020 Jan;228(1):e13298
pubmed: 31077538
Cancer Res. 2008 May 15;68(10):3609-17
pubmed: 18483242
J Immunol. 2000 Dec 15;165(12):7199-206
pubmed: 11120852
Chemosphere. 2008 Dec;74(1):149-54
pubmed: 18840388
Reprod Toxicol. 2017 Mar;68:3-33
pubmed: 27760374
PLoS One. 2014 Jan 10;9(1):e84816
pubmed: 24427296
PLoS One. 2015 Jun 03;10(6):e0127952
pubmed: 26039703
J Endocrinol. 2004 Oct;183(1):145-54
pubmed: 15525582
Comp Biochem Physiol C Toxicol Pharmacol. 2009 Sep;150(3):383-9
pubmed: 19539049
Toxicol Sci. 2006 Oct;93(2):223-41
pubmed: 16829543
Biochem Pharmacol. 2009 Feb 15;77(4):734-45
pubmed: 18955032
Pflugers Arch. 2011 Sep;462(3):469-77
pubmed: 21698390
Biofactors. 2014 Sep-Oct;40(5):513-23
pubmed: 25110893
Environ Health. 2003 Dec 16;2(1):16
pubmed: 14678569
Toxicol Sci. 2004 Mar;78(1):68-77
pubmed: 14691204
Kidney Int. 1997 Feb;51(2):567-74
pubmed: 9027741
Cancer Res. 2010 Sep 1;70(17):6837-48
pubmed: 20736373
Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E333-42
pubmed: 19066318
J Biol Chem. 2010 May 7;285(19):14558-64
pubmed: 20228066
Mol Endocrinol. 2000 Oct;14(10):1674-81
pubmed: 11043581
Int J Obes (Lond). 2012 Sep;36(9):1170-5
pubmed: 21946706
J Inorg Biochem. 2014 Apr;133:63-72
pubmed: 24468676
Environ Toxicol Pharmacol. 2001 Jun;10(1-2):17-27
pubmed: 11382553
Toxicol Appl Pharmacol. 2007 Aug 15;223(1):28-38
pubmed: 17599377
Environ Sci Pollut Res Int. 2018 Jun;25(17):16481-16492
pubmed: 28699004
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):23-9
pubmed: 15556062
Sci Rep. 2018 Jan 11;8(1):523
pubmed: 29323267
Am J Physiol Cell Physiol. 2020 Jun 1;318(6):C1078-C1082
pubmed: 32208988
Chem Biol Interact. 2014 Jul 25;218:82-8
pubmed: 24824450
J Biol Chem. 2002 Sep 13;277(37):34601-9
pubmed: 12084725
Biomarkers. 2003 Nov-Dec;8(6):529-34
pubmed: 15195683
Br J Nutr. 2004 Sep;92(3):347-55
pubmed: 15469638
Adipocyte. 2014 Jan 1;3(1):75-80
pubmed: 24575375
Sci Rep. 2016 Jun 13;6:27882
pubmed: 27292372
J Transl Med. 2016 Jul 15;14(1):212
pubmed: 27421877
Diabetes Obes Metab. 2018 Sep;20(9):2286-2290
pubmed: 29687584
Obes Surg. 2005 Jun-Jul;15(6):813-9
pubmed: 15978153
Biochem J. 2009 Apr 15;419(2):419-25
pubmed: 19154183
Oncogene. 2012 May 17;31(20):2555-65
pubmed: 21996739
J Biol Chem. 2002 Nov 8;277(45):42953-7
pubmed: 12215445
Toxicol Appl Pharmacol. 2008 May 15;229(1):10-9
pubmed: 18295293
Environ Health Perspect. 2015 Oct;123(10):944-50
pubmed: 25734695
Biochim Biophys Acta. 2014 Mar;1842(3):520-33
pubmed: 23735214
Mol Pharmacol. 1999 Dec;56(6):1127-37
pubmed: 10570039
Obesity (Silver Spring). 2011 Apr;19(4):709-14
pubmed: 20559302
Chem Res Toxicol. 2008 Feb;21(2):341-8
pubmed: 18072750
Environ Health Perspect. 2012 Mar;120(3):451-7
pubmed: 22027556
Diabetes. 2009 Mar;58(3):718-25
pubmed: 19074987
J Biol Chem. 2013 Feb 8;288(6):3844-57
pubmed: 23255598
Biomed Res Int. 2015;2015:549412
pubmed: 26146622
Biochem Pharmacol. 2000 Jun 15;59(12):1549-56
pubmed: 10799651
Nat Metab. 2019 Jan;1(1):86-97
pubmed: 31528845
Int J Obes (Lond). 2008 Mar;32(3):451-63
pubmed: 17895881
J Clin Invest. 2020 Dec 1;130(12):6688-6699
pubmed: 33164985
J Transl Med. 2015 Nov 30;13:373
pubmed: 26619907

Auteurs

Zeinab El Amine (ZE)

School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada.

Jean-François Mauger (JF)

School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada.

Pascal Imbeault (P)

School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Institut du Savoir Montfort, Hôpital Montfort, Ottawa, ON K1K 0T2, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH